ES2284485T3 - Uso de 4-aminopiridina para el tratamiento de neuropatias perifericas. - Google Patents

Uso de 4-aminopiridina para el tratamiento de neuropatias perifericas. Download PDF

Info

Publication number
ES2284485T3
ES2284485T3 ES00911753T ES00911753T ES2284485T3 ES 2284485 T3 ES2284485 T3 ES 2284485T3 ES 00911753 T ES00911753 T ES 00911753T ES 00911753 T ES00911753 T ES 00911753T ES 2284485 T3 ES2284485 T3 ES 2284485T3
Authority
ES
Spain
Prior art keywords
treatment
nervous system
patients
subject
aminopyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00911753T
Other languages
English (en)
Spanish (es)
Inventor
Jay M. Meythaler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Application granted granted Critical
Publication of ES2284485T3 publication Critical patent/ES2284485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES00911753T 1999-02-09 2000-02-09 Uso de 4-aminopiridina para el tratamiento de neuropatias perifericas. Expired - Lifetime ES2284485T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11927399P 1999-02-09 1999-02-09
US119273P 1999-02-09

Publications (1)

Publication Number Publication Date
ES2284485T3 true ES2284485T3 (es) 2007-11-16

Family

ID=22383494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00911753T Expired - Lifetime ES2284485T3 (es) 1999-02-09 2000-02-09 Uso de 4-aminopiridina para el tratamiento de neuropatias perifericas.

Country Status (10)

Country Link
US (1) US6503931B1 (enExample)
EP (1) EP1152760B1 (enExample)
JP (1) JP2002536413A (enExample)
AT (1) ATE357914T1 (enExample)
AU (1) AU3360000A (enExample)
CA (1) CA2360326C (enExample)
DE (1) DE60034110T2 (enExample)
DK (1) DK1152760T3 (enExample)
ES (1) ES2284485T3 (enExample)
WO (1) WO2000047210A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
CA2840591A1 (en) 2011-06-30 2013-01-03 Biomarin Pharmaceuticals, Inc. Methods of administering 3,4-diaminopyridine
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法
US9993429B2 (en) 2013-03-15 2018-06-12 University Of Rochester Composition and methods for the treatment of peripheral nerve injury
MA35698B1 (fr) * 2013-05-16 2014-12-01 Univ Mohammed V Souissi Nouvelle composition du 3,4-diaminopyridin pour le traitement de la fatigabilité musculaire associée à des troubles neurovégétatifs.
WO2024011220A1 (en) 2022-07-08 2024-01-11 University Of Rochester Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating tissue dysfunction caused by toxic insults

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition

Also Published As

Publication number Publication date
DE60034110D1 (de) 2007-05-10
EP1152760A1 (en) 2001-11-14
US6503931B1 (en) 2003-01-07
EP1152760B1 (en) 2007-03-28
ATE357914T1 (de) 2007-04-15
CA2360326C (en) 2011-04-05
CA2360326A1 (en) 2000-08-17
DK1152760T3 (da) 2007-07-30
DE60034110T2 (de) 2007-12-06
WO2000047210A1 (en) 2000-08-17
JP2002536413A (ja) 2002-10-29
AU3360000A (en) 2000-08-29
EP1152760A4 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
ES2284485T3 (es) Uso de 4-aminopiridina para el tratamiento de neuropatias perifericas.
Gyory et al. Orudis in management of rheumatoid arthritis and osteoarthrosis of the hip: comparison with indomethacin
Lingam et al. Hereditary stiff-baby syndrome
Ansell Management of polymyositis and dermatomyositis
Roig et al. Carbamazepine: an alternative drug for the treatment of nonhereditary chorea
Kim et al. Efficacy and safety of montelukast+ levocetirizine combination therapy compared to montelukast monotherapy for allergic rhinitis in children
JP2024535431A (ja) シェーグレン症候群の治療及び予防におけるｃｄ４０ｌ特異的ｔｎ３由来足場
Stern et al. Neonatal myasthenia gravis
Moudgil et al. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin
Lindor et al. A neuropsychiatric disorder associated with dense calcification of the external ears and distal muscle wasting:'Primrose syndrome'
Ruddy et al. Management of tricyclic antidepressant ingestion in children with special reference to the use of glucagon
Giuffrè et al. New syndrome: Autosomal dominant microcephaly and radio‐ulnar synostosis
Clifton Guillain-Barré syndrome, pregnancy, and plasmapheresis
Baumelou et al. Medical nephrectomy with anti-inflammatory non-steroidal drugs
Haverkamp et al. Craniometaphyseal dysplasia as a rare cause of a severe neonatal nasal obstruction
Mowat et al. Naproxen in rheumatoid arthritis. Extended trial.
Lopate et al. Inflammatory demyelinating neuropathies
Yale et al. Fever, rash, and angioedema after a course of allopurinol
Sunarto et al. Juvenile dermatomyositis in a 6 year old boy: A rare case
Reid et al. Tachycardia precipitated by topical homatropine
Santone et al. Tardive dyskinesia remission during risperidone therapy
Patterson et al. Efficacy and safety of arimoclomol in patients with Niemann-Pick disease type C: Results from a double-blind, randomized placebo-controlled trial with a novel treatment
Rogers Rheumatoid arthritis: Psychiatric aspects and use of psychotropics
ROBERTS Syphilitic and tuberculous joints
Minford et al. The effect of baclofen on the gait of hemiplegic children assessed by means of polarised light goniometry